Nosenzo John's Form 4 filing
Bioventus Inc. (BVS) · filed Apr 21, 2023
- Accession no.
- 0001578563-23-000026
- Filed
- Apr 21, 2023
- Trade date
- Apr 1-Oct 3, 2022
- Filing delay
- 385 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.25K. It was filed 385 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nosenzo JohnCIK 0001835973 | Officer (Fmr. Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Class A Common Stock | SSaleDisposed | −40 | $14.07 | −$562.8 | 87,250 | Direct | |
| Jul 1, 2022 | Class A Common Stock | SSaleDisposed | −95 | $6.73 | −$639.35 | 87,155 | Direct | |
| Oct 3, 2022 | Class A Common Stock | SSaleDisposed | −7 | $7.00 | −$49 | 87,148 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.